​

Funding Round

Series B - Ketai Bio

Series B - Ketai Bio

Investment Firm

Overview

Cataya Bio is a synthetic biology startup specializing in the biomanufacturing of chemical and biochemical products.

Announced Date

Sep 04, 2023

Closed on Date

Sep 04, 2023

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

Eight Roads Ventures

Eight Roads Ventures

Eight Roads Ventures is a early_stage_venture and late_stage_venture and venture firm.

Hengxu Capital

Hengxu Capital

Hengxu Capital is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorHengxu Capital
Participant InvestorBits x Bites
Participant InvestorEight Roads Ventures

Round Details and Background

Ketai Bio raised $34374184 on 2023-09-04 in Series B

Cataya Bio is a synthetic biology startup specializing in the biomanufacturing of chemical and biochemical products.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 06, 2022
Series A - Ketai Bio
4-13.9M
May 09, 2022
Series A - Ketai Bio
2-14.9M
Sep 04, 2023
Series B - Ketai Bio
4-34.4M

Recent Activity

There is no recent news or activity for this profile.